The interactions of inducers, inhibitors, and substrates of drug-metabolizing enzymes with rat liver cytochrome P-450.
D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D006591:Hexobarbital / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology*; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D009536:Niacinamide / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology; D012313:RNA / Q000378:metabolism; D051381:Rats; D013053:Spectrophotometry
D000814:Aniline Compounds; D001463:Barbiturates; D010627:Phenethylamines; D011506:Proteins; D009536:Niacinamide; D011691:Puromycin; D012313:RNA; D003577:Cytochrome P-450 Enzyme System; D011335:Proadifen; D006591:Hexobarbital; D010634:Phenobarbital